BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Chapter

Reset

Presentation	Product	Chemical substance	Chapter	Items dispensed
Betamethasone valerate 0.1% oint 25%/Coal tar soln 5% in WSP 1304000F0AAESES	Betamethasone valerate (Topical)	Betamethasone valerate	Skin	No data available
Betamethasone valerate 0.1% oint 25%/Coal tar soln 6% in WSP 1304000F0AAENEN	Betamethasone valerate (Topical)	Betamethasone valerate	Skin	No data available
Betamethasone valerate 0.1% oint 25%/Ichthammol 1% in YSP 1304000F0AAEMEM	Betamethasone valerate (Topical)	Betamethasone valerate	Skin	No data available
Betamethasone valerate 0.1% oint 30%/Coal tar soln 5% in YSP 1304000F0AAFIFI	Betamethasone valerate (Topical)	Betamethasone valerate	Skin	No data available
Betamethasone valerate 0.1% oint 33% in White soft paraffin 1304000F0AADVDV	Betamethasone valerate (Topical)	Betamethasone valerate	Skin	No data available
Betamethasone valerate 0.1% oint 40% in White soft paraffin 1304000F0AADYDY	Betamethasone valerate (Topical)	Betamethasone valerate	Skin	No data available
Betamethasone valerate 0.1% oint 5% in White soft paraffin 1304000F0AACTCT	Betamethasone valerate (Topical)	Betamethasone valerate	Skin	No data available
Betamethasone valerate 0.1% oint 50% in Emulsifying oint 1304000F0AACNCN	Betamethasone valerate (Topical)	Betamethasone valerate	Skin	No data available
Betamethasone valerate 0.1% oint 50% in Yellow soft paraffin 1304000F0AADZDZ	Betamethasone valerate (Topical)	Betamethasone valerate	Skin	No data available
Betamethasone valerate 0.1% ointment 50% in Aqueous cream 1304000F0AAFRFR	Betamethasone valerate (Topical)	Betamethasone valerate	Skin	No data available
Betamethasone valerate 0.1% ointment 50% in Coal tar paste 1304000F0AAEHEH	Betamethasone valerate (Topical)	Betamethasone valerate	Skin	No data available
Betamethasone valerate 0.1% ointment 50% in Hydrous ointment 1304000F0AADADA	Betamethasone valerate (Topical)	Betamethasone valerate	Skin	No data available
Betesil 2.25mg medicated plasters (Genus) 1304000F0BFAADW	Betesil	Betamethasone valerate	Skin	No data available
Betnovate-N ointment 1304000F0BBANCE	Betnovate (Topical)	Betamethasone valerate	Skin	No data available
Bismuth subnitrate and Iodoform paste 131005000AAAEAE	Generic compound preparation BNF 1310050	Other minor cut and abrasion preparations	Skin	No data available
Bite and Sting Relief Antihistamine 2% cream 1303000M0BDAAAA	Boots Bite and Sting Relief	Mepyramine maleate	Skin	No data available
Boots Anti-Dandruff 2% shampoo 1309000I0BGAAAA	Boots (Ketoconazole)	Ketoconazole	Skin	No data available
Boots Antifungal 1% cream 1310020H0BFABAB	Boots antifungal	Clotrimazole	Skin	No data available
Boots Antiseptic cream 131005000BBAIA0	Proprietary compound preparation BNF 1310050	Other minor cut and abrasion preparations	Skin	No data available
Boots Antiseptic Nappy Rash cream 1302020D0BIAAAH	Boots (Dimeticone)	Dimeticone (Barrier)	Skin	No data available
Boots Antiseptic Wound Wash 0.5% spray 1310050D0BNACAF	Boots (Topical antiseptic)	Cetrimide	Skin	No data available
Boots Baby Sensitive Skin moisturising cream 130201000BBJNA0	Proprietary compound emollients	Other emollient preparations	Skin	No data available
Boots Bite and Sting Relief Hydrocortisone 1% cream 1304000X0BNAAAA	Boots Bite and Sting Relief (Hydrocortisone)	Hydrocortisone acetate	Skin	No data available
Boots Chilblain cream 131400000BLAAA0	Proprietary compound preparation BNF 1314000	Other topical circulatory preparations	Skin	No data available
Boots Cold Sore lotion 131003000BLBCA0	Proprietary compound preparation BNF 1310030	Other antiviral preparations	Skin	No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.